Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression

American Journal of Roentgenology

Volumn 193, Issue 3, 2009, Pages 757-763

  Park, Yulri ^a   Kim, Young Sun ^a   Rhim, Hyunchul ^a   Hyo, Keun Lim ^a   Choi, Dongil ^a   Won, Jae Lee ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

CT; Hepatocellular carcinoma; Oncologic imaging; Radiofrequency ablation

Indexed keywords

IOPROMIDE;

ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK FACTOR; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

AGED; ARTERIES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; HUMANS; IOHEXOL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 69949102943     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.2202     Document Type: Article

References (29)

1. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17:684-692 (Pubitemid 46252347)
2. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008; 47:82-89 (Pubitemid 351171044)
3. Yan K, Chen MH, Yang W, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 2008; 67:336-347 (Pubitemid 351952310)
4. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240 (Pubitemid 36736097)
5. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-391 (Pubitemid 30677826)
6. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 2007; 14:2319-2329 (Pubitemid 47174899)
7. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005; 103:1201-1209 (Pubitemid 40328091)
8. Horiike N, Iuchi H, Ninomiya T, et al. Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep 2002; 9:1059-1062
9. Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 2006; 59:432-441 (Pubitemid 44301741)
10. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR 2007; 188:480-488 (Pubitemid 46170753)
11. Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003; 38:977-981 (Pubitemid 37455785)
12. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242:158-171 (Pubitemid 41033431)
13. Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97:1253-1262 (Pubitemid 36237312)
14. Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors. AJR 2006; 186:686[5 suppl]:S269-S274 (Pubitemid 46114730)
15. Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14:1267-1274 (Pubitemid 37266660)
16. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236
17. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235:728-739 (Pubitemid 40695866)
18. Sultana S, Awai K, Nakayama Y, et al. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 2007; 243:140-147 (Pubitemid 46579704)
19. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328 (Pubitemid 43327762)
20. Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008; 12:192-198
21. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39:247-252
22. Vivarelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240:102-107 (Pubitemid 38808241)
23. Wakai T, Shirai Y, Suda T, et al. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or = 4 cm. World J Gastroenterol 2006; 12:546-552 (Pubitemid 43380783)
24. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 2002; 225:143-149
25. Kim CK, Lim JH, Park CK, Choi D, Lim HK, Lee WJ. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. Radiology 2005; 237:529-534
26. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999; 19:12-18 (Pubitemid 29034105)
27. Zytoon AA, Ishii H, Murakami K, et al. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma: a registry report of the impact of risk factors on outcome. Jpn J Clin Oncol 2007; 37:658-672 (Pubitemid 47617785)
28. Kim SH, Lim HK, Choi D, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR 2006; 186[5 suppl]:S327-S333 (Pubitemid 46114739)
29. Kim YS, Lee WJ, Rhim H, Lim HK. Relationships between ablative margin and local tumor progression after radiofrequency ablation of hepatocellular carcinoma: quantitative analysis using CT image fusion. Abstract book of the annual Meeting of World Conference on Interventional Oncology. Los Angeles, CA: Society of Interventional Oncology, 2008